<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03459001</url>
  </required_header>
  <id_info>
    <org_study_id>BL32</org_study_id>
    <nct_id>NCT03459001</nct_id>
  </id_info>
  <brief_title>Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Population With or at Risk of Malnutrition</brief_title>
  <official_title>A Prospective, Observational Study to Evaluate the Use of a High Calorie, High Protein Tube Feeding Product in an Adult Population With or at Risk of Malnutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, observational study is designed to observe the use of a high calorie, high&#xD;
      protein tube feed product in adults that are malnourished or at risk of malnutrition, as&#xD;
      assessed by a clinician, and have been placed on a nutritional care plan which includes a&#xD;
      tube feeding formula, per standard of care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 8, 2018</start_date>
  <completion_date type="Actual">February 7, 2019</completion_date>
  <primary_completion_date type="Actual">February 7, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tube Feed Product Compliance</measure>
    <time_frame>Day 1 to Day 20</time_frame>
    <description>Average Daily Intake and Proportion of Days Compliant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Day 0 to Day 20</time_frame>
    <description>Non serious AE and SAE collection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>Day 0 to Day 20</time_frame>
    <description>Weight, Height</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Tube Fed Malnourished Outpatients</arm_group_label>
    <description>Outpatients that are malnourished or at risk of malnutrition and have been placed on a nutritional care plan, which includes a complete tube feeding formula as sole source nutrition</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tube Feeding Product</intervention_name>
    <description>a high calorie, high protein tube feed product consumed sole source per their physician's recommendation and per standard of care</description>
    <arm_group_label>Tube Fed Malnourished Outpatients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients ≥ 18 years of age that are malnourished or at risk of malnutrition and have&#xD;
        been placed on a nutritional care plan, which includes a complete tube feeding formula as&#xD;
        sole source nutrition will be recruited.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Malnourished or at risk for malnutrition based on the Malnutrition Universal Tool&#xD;
             (MUST) score ≥ 2.&#xD;
&#xD;
          -  Under the care of a health care professional for malnutrition or at risk of&#xD;
             malnutrition and has been prescribed the study formula.&#xD;
&#xD;
          -  Requires and agrees to be tube fed the enteral feeding product for at least 16&#xD;
             consecutive days as their sole-source of nutritional intake.&#xD;
&#xD;
          -  Free living in the community or is residing in a nursing home.&#xD;
&#xD;
          -  Conforms to the requirements set forth on the study product label.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently taking or has taken antibiotics within 2 weeks prior to enrollment.&#xD;
&#xD;
          -  Consuming food PO.&#xD;
&#xD;
          -  Current active cancer and the study physician determines that the subject is not&#xD;
             suitable for the study.&#xD;
&#xD;
          -  History of diabetes mellitus as evidenced by taking anti-hyperglycemic medications or&#xD;
             by self-reported dietary modification for control of diabetes mellitus.&#xD;
&#xD;
          -  Renal or liver failure.&#xD;
&#xD;
          -  Pregnant as demonstrated by self-report.&#xD;
&#xD;
          -  Severe auto immune disease (per physician's discretion) and is on immuno-modulating&#xD;
             therapy.&#xD;
&#xD;
          -  History of allergy to any of the ingredients in the study product.&#xD;
&#xD;
          -  Active Human Immunodeficiency Virus (HIV).&#xD;
&#xD;
          -  Known dementia, brain metastases, eating disorders, history of significant&#xD;
             neurological or psychiatric disorder, or any other psychological condition that may&#xD;
             interfere with study product consumption and does not have a caregiver who can assist&#xD;
             them with adherence to the study protocol.&#xD;
&#xD;
          -  Condition that is contraindicated to tube feeding the study product.&#xD;
&#xD;
          -  Taking part in a non-approved clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Camprubi Robles, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Residencia Plata y Castañar</name>
      <address>
        <city>Madrid</city>
        <zip>28021</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Residencia Albertia Moratalaz</name>
      <address>
        <city>Madrid</city>
        <zip>28030</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Residencia Valle de la Oliva</name>
      <address>
        <city>Madrid</city>
        <zip>28220</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe 3065</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe 3066</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe de Valencia 3033</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 2, 2018</study_first_submitted>
  <study_first_submitted_qc>March 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>April 18, 2019</last_update_submitted>
  <last_update_submitted_qc>April 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

